Parallel Advisors’s Opko Health OPK Stock Holding History

Parallel Advisors’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.97K	Sell	2,649 -1,000	-27%	-$1.27K	﹤0.01%	3306
2026 Q1	$4.16K	Buy	+3,649	New	+$4.49K	﹤0.01%	3103
2024 Q1	–	Sell	-1,208	Closed	-$1.82K	–	3391
2023 Q4	$1.82K	Hold	1,208	–	–	﹤0.01%	2829
2023 Q3	$1.93K	Sell	1,208 -443	-27%	-$807	﹤0.01%	2832
2023 Q2	$3.58K	Sell	1,651 -1,317	-44%	-$2.06K	﹤0.01%	2549
2023 Q1	$4.33K	Buy	2,968 +935	+46%	+$1.2K	﹤0.01%	2463
2022 Q4	$2.54K	Buy	2,033 +1,208	+146%	+$1.9K	﹤0.01%	2596
2022 Q3	$2K	Buy	825 +404	+96%	+$955	﹤0.01%	2713
2022 Q2	$1K	Buy	421 +260	+161%	+$758	﹤0.01%	2823
2022 Q1	$1K	Hold	161	–	–	﹤0.01%	2798
2021 Q4	$1K	Hold	161	–	–	﹤0.01%	2922
2021 Q3	$1K	Hold	161	–	–	﹤0.01%	2919
2021 Q2	$1K	Hold	161	–	–	﹤0.01%	2787
2021 Q1	$1K	Buy	+161	New	+$769	﹤0.01%	2664
2018 Q1	–	Sell	-8	Closed	–	–	2148
2017 Q4	$0	Sell	8 -353	-98%	-$2.05K	﹤0.01%	2121
2017 Q3	$2K	Buy	361 +353	+4,413%	+$2.23K	﹤0.01%	1870
2017 Q2	$0	Hold	8	–	–	﹤0.01%	2176
2017 Q1	$0	Hold	8	–	–	﹤0.01%	2053
2016 Q4	$0	Buy	+8	New	+$83	﹤0.01%	1786

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parallel Advisors's OPK Position: Q2 2026 in Review

Parallel Advisors reduced its Opko Health (OPK) stake by 27% in Q2 2026, selling an estimated $1.27K and leaving 2,649 shares worth $3.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3306.

Parallel Advisors first reported a position in OPK in Q4 2016 and has held it in 19 quarters since. The position peaked at $4.33K in Q1 2023. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

Parallel Advisors held 2,649 shares of Opko Health worth $3.97K as of Q2 2026.
Parallel Advisors sold 1,000 Opko Health shares in Q2 2026, an estimated $1.27K.
Opko Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3306 holding.
Parallel Advisors first reported a position in Opko Health in Q4 2016 and has held it in 19 quarters since.
Parallel Advisors's Opko Health position peaked at $4.33K in Q1 2023.
222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.